Skip to main content

Evonik expands in pharma in Germany

Evonik, which is one of the world’s largest pharmaceutical CDMOs, has announced the €25 million first stage of a long-term programme to expand API and advanced intermediates capacity at its sites in Dossenheim and Hanau, Germany. This should be completed by mid-2021 and the whole project should be finalised prior to 2024.

Sanofi to establish API player

Big Pharma giant Sanofi has announced plans to create a stand-alone company dedicated to the production and marketing of APIs to third parties.

Ampac reopens Virginia site

US-based API manufacturer Ampac Fine Chemicals (AFC) has officially reopened the manufacturing operations of its AFC-Virginia facility in front of state and local dignitaries and other guests.

Thermo Fisher buys GSK Irish site

Thermo Fisher Scientific, owner of Patheon, has agreed to acquire a drug substance manufacturing site in Cork, Ireland, from GlaxoSmithKline (GSK) for about €90 million.

Ten die in Chinese pharma plant accident

Ten workers were killed in an accident at a pharmaceutical intermediates and APIs plant in China’s Shandong province on 15 April, it has emerged. This was the second fatal industrial accident at a chemicals-related plant in China within the space of a month.
Subscribe to APIs

 

 

 

AMRI banner advert